Clinical Trial Update: Safety and Efficacy of MiSaver (CB Cells) for Acute Myocardial Infarction, Phase II [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating the safety and efficacy of MiSaver (CB Cells) for acute myocardial infarction; the study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• MiSaver (Stem cell treatment)

Snippet

Sponsor: HONYA Medical Co Ltd | Conditions: Acute Myocardial Infarction (AMI) | Phase 2 | Status: NOT_YET_RECRUITING